إعلان
إعلان

TMO

TMO logo

Thermo Fisher Scientific, Inc.

606.03
USD
برعاية
-11.12
-1.80%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

605.97

-0.06
-0.01%

تقارير أرباح TMO

النسبة الإيجابية المفاجئة

TMO تفوق 33 من 39 آخر التقديرات.

85%

التقرير التالي

بيانات التقرير القادم
٢٩ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$12.07B
/
$6.51
التغير الضمني من Q3 25 (Revenue/ EPS)
+8.55%
/
+12.44%
التغير الضمني من Q4 24 (Revenue/ EPS)
+5.95%
/
+6.72%

Thermo Fisher Scientific, Inc. earnings per share and revenue

On ٢٢ أكتوبر ٢٠٢٥, TMO reported earnings of 5.79 USD per share (EPS) for Q3 25, beating the estimate of 5.54 USD, resulting in a 4.37% surprise. Revenue reached 11.12 مليار, compared to an expected 11.02 مليار, with a 0.96% difference. The market reacted with a +1.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 المحللين forecast an EPS of 6.51 USD, with revenue projected to reach 12.07 مليار USD, implying an زيادة of 12.44% EPS, and زيادة of 8.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Thermo Fisher Scientific, Inc. reported EPS of $5.79, beating estimates by 4.37%, and revenue of $11.12B, 0.96% above expectations.
The stock price moved up 1.65%, changed from $557.99 before the earnings release to $567.20 the day after.
The next earning report is scheduled for ٢٩ يناير ٢٠٢٦.
Based on 22 المحللين, Thermo Fisher Scientific, Inc. is expected to report EPS of $6.51 and revenue of $12.07B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان